Ftse Mib
34.625,80
0,83%
DAX
18.772,85
0,50%
S&P 500
5.222,01
0,15%
NASDAQ
16.339,28
-0,04%
Bitcoin
60.717,08
-3,70%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. AMEX AgeX Therapeutics Inc (AGE) AgeX Therapeutics Inc (AGE) Notizie

AGE

AgeX Therapeutics (AGE)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:AGE
DataOraFonteTitoloSimboloCompagnia
22/03/202422:27GlobeNewswire Inc.AgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial ResultsAMEX:AGEAgeX Therapeutics Inc
07/03/202422:49Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsAMEX:AGEAgeX Therapeutics Inc
07/03/202422:47Edgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
07/03/202413:47Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:AGEAgeX Therapeutics Inc
14/02/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:AGEAgeX Therapeutics Inc
18/01/202423:29Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:AGEAgeX Therapeutics Inc
16/01/202415:11Edgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]AMEX:AGEAgeX Therapeutics Inc
15/11/202315:38Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:AGEAgeX Therapeutics Inc
14/11/202322:05Business WireAgeX Therapeutics Reports Third Quarter 2023 Financial ResultsAMEX:AGEAgeX Therapeutics Inc
07/11/202322:06Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:AGEAgeX Therapeutics Inc
22/09/202322:05Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsAMEX:AGEAgeX Therapeutics Inc
30/08/202313:00Business WireSerina Therapeutics and AgeX Therapeutics Enter into Merger AgreementAMEX:AGEAgeX Therapeutics Inc
14/08/202322:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:AGEAgeX Therapeutics Inc
14/08/202322:05Business WireAgeX Therapeutics Reports Second Quarter 2023 Financial ResultsAMEX:AGEAgeX Therapeutics Inc
25/07/202300:28Business WireAgeX Therapeutics Closes $36,000,000 Debt Exchange for Preferred StockAMEX:AGEAgeX Therapeutics Inc
21/07/202323:32Business WireAgeX Therapeutics Announces $36,000,000 Debt Exchange for Preferred StockAMEX:AGEAgeX Therapeutics Inc
08/06/202322:06Edgar (US Regulatory)Current Report Filing (8-k)AMEX:AGEAgeX Therapeutics Inc
23/05/202322:05Business WireAgeX Therapeutics Announces Appeal of NYSE American DeterminationAMEX:AGEAgeX Therapeutics Inc
18/05/202322:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:AGEAgeX Therapeutics Inc
12/05/202322:05Business WireAgeX Therapeutics Reports First Quarter 2023 Financial ResultsAMEX:AGEAgeX Therapeutics Inc
26/04/202322:05Business WireAgeX Therapeutics Receives Stock Exchange Deficiency LetterAMEX:AGEAgeX Therapeutics Inc
31/03/202322:05Business WireAgeX Therapeutics Reports Fourth Quarter and Annual 2022 Financial ResultsAMEX:AGEAgeX Therapeutics Inc
22/03/202321:20Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:AGEAgeX Therapeutics Inc
22/03/202321:17Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)AMEX:AGEAgeX Therapeutics Inc
06/02/202322:07Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)AMEX:AGEAgeX Therapeutics Inc
25/11/202221:41Business WireAgeX Therapeutics Receives Extension of Time to Attain Compliance With Stock Exchange Continued Listing RequirementsAMEX:AGEAgeX Therapeutics Inc
10/11/202222:21Edgar (US Regulatory)Quarterly Report (10-q)AMEX:AGEAgeX Therapeutics Inc
10/11/202222:05Business WireAgeX Therapeutics Reports Third Quarter 2022 Financial ResultsAMEX:AGEAgeX Therapeutics Inc
02/11/202221:48Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:AGEAgeX Therapeutics Inc
05/10/202222:07Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)AMEX:AGEAgeX Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:AGE

La tua Cronologia

LSE
10G5
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network